Bioinformatics companies in California merge biology and technology to develop solutions that analyze complex biological data, especially genomic data. These firms foster innovation in healthcare across areas like drug development, diagnostics, and personalized medicine. By harnessing artificial intelligence and advanced analytics, they're at the forefront of researchers' quest to understand genetic diseases and improve patient outcomes. The industry is rapidly evolving, with advancements in sequencing technologies and data integration leading to more precise treatments. Innovations from this sector promise to democratize access to genetic information, reflecting a transformative shift in modern medicine.


The companies featured in this list range from small startups to established firms, varying in size from around 10 to 500 employees. Most are headquartered across California, a hub for biotech innovation. Established between 1993 and 2022, these companies specialize in cutting-edge developments such as genomic data analysis, protein research, and bioinformatics software. Together, they contribute significantly to advancements in areas like precision medicine and genetic research, showcasing their impactful role in science and healthcare.


Continue reading to discover the top bioinformatics companies in California.


Top 24 Bioinformatics Companies in California


1. DNAnexus

  • Website: dnanexus.com
  • Ownership type: Private Equity
  • Headquarters: Mountain View, California, United States (USA)
  • Employee distribution: Czech Republic 49%, United States (USA) 42%, Vietnam 5%, Other 4%
  • Latest funding: Series E-K, $200.0M, March 2022
  • Founded year: 2009
  • Headcount: 201-500
  • LinkedIn: dnanexus

DNAnexus, founded in 2009 and based in Mountain View, California, is a private equity-backed company that specializes in cloud-based data analysis for genomic research. The company offers a robust platform designed to manage and analyze DNA sequence data, catering primarily to biomedical organizations such as pharmaceutical companies and academic medical centers. DNAnexus provides a suite of bioinformatics tools and professional services aimed at enhancing research efficiency and improving patient outcomes. With over 105 petabytes of precision health data on its platform and a user base exceeding 45,000, DNAnexus plays a pivotal role in the bioinformatics industry. The company has also attracted substantial investment, with its latest funding round raising $200 million in March 2022, underscoring its growth potential and commitment to advancing genomic data analysis.


2. Partek, an Illumina company

  • Website: partek.com
  • Ownership type: Private
  • Headquarters: San Diego, California, United States (USA)
  • Employee distribution: Australia 33%, United States (USA) 33%, Singapore 33%
  • Founded year: 1993
  • Headcount: 11-50
  • LinkedIn: partek-inc

Partek, an Illumina company, is a bioinformatics firm based in San Diego, California, founded in 1993. With a team of around 16 employees, Partek develops software solutions that facilitate genomic data analysis. Their flagship products, Partek Flow and Partek Pathway, are tailored for researchers in academia and industry, enabling efficient analysis of complex genomic datasets. The company specializes in various applications, including single cell analysis, proteomics, and multiomics, which are essential for advancing genomic research. Partek's software is designed to be user-friendly, providing powerful statistical tools and interactive visualizations that help researchers interpret their data effectively. The company has established a strong presence in the bioinformatics field, supporting a wide range of genomic applications and collaborating with major vendors in the industry.


3. Ingenuity Web Apps

  • Website: ingenuity.com
  • Ownership type: Corporate
  • Headquarters: Redwood City, California, United States (USA)
  • Latest funding: April 2013
  • Founded year: 1998
  • Headcount: 51-200
  • LinkedIn: ingenuitywebapps

Ingenuity Web Apps, now part of QIAGEN Digital Insights, is a bioinformatics company based in Redwood City, California. Founded in 1998, the company has carved out a niche in providing advanced software solutions for genomic data analysis and interpretation. Their offerings are tailored for researchers and clinical laboratories, enabling them to extract meaningful insights from complex genomic datasets. Ingenuity Web Apps is particularly known for its tools like the Ingenuity Pathway Analysis (IPA) and QCI Interpret, which assist in the analysis and reporting of next-generation sequencing (NGS) data. The company emphasizes the integration of artificial intelligence with human expertise to enhance molecular intelligence, making their solutions vital for modern genomic research and clinical applications. With a workforce of around 62 employees, they continue to innovate in the biotechnology and healthcare sectors, focusing on areas such as oncology and hereditary diseases.


4. Arima Genomics

  • Website: arimagenomics.com
  • Ownership type: Venture Capital
  • Headquarters: Carlsbad, California, United States (USA)
  • Employee distribution: United States (USA) 91%, Spain 4%, United Kingdom (UK) 4%
  • Latest funding: Series B, $7.0M, March 2022
  • Founded year: 2015
  • Headcount: 11-50
  • LinkedIn: arima-genomics-inc-

Arima Genomics, founded in 2015 and based in Carlsbad, California, is a biotechnology firm that specializes in genomics and life sciences. The company offers a range of products and services designed to support researchers in cancer genomics and human health. Their innovative solutions include advanced genomic technologies such as Genome-Wide HiC and various bioinformatics platforms. Arima Genomics aims to provide tools that facilitate genomic research and diagnostics, helping scientists uncover novel biomarkers and therapeutic targets. The company has received $7 million in Series B funding as of March 2022, reflecting strong investor confidence in their technology and market potential. With a dedicated team of scientists and a focus on enhancing genomic insights, Arima Genomics is positioned as a significant player in the bioinformatics industry.


5. Dovetail Genomics

  • Website: dovetailgenomics.com
  • Ownership type: Private
  • Headquarters: Scotts Valley, California, United States (USA)
  • Employee distribution: United States (USA) 83%, United Kingdom (UK) 9%, Australia 9%
  • Latest funding: Other (Grant), $2.0M, November 2024
  • Founded year: 2013
  • Headcount: 11-50
  • LinkedIn: dovetail-genomics-llc

Dovetail Genomics, founded in 2013 and based in Scotts Valley, California, is a private biotechnology firm that specializes in genomic solutions. The company offers a range of products and services aimed at genome assembly and epigenetics, catering to researchers and clinicians across various scientific fields. Dovetail's innovative technologies, such as their Hi-C kits, enable high-resolution genome assembly and provide insights into chromatin structure and genetic variation. Their commitment to advancing genomic research is evident through their partnerships and collaborations, as well as their recent funding of $2 million in November 2024. This funding supports their ongoing development of multi-omic products that enhance the understanding of genetic information. Dovetail Genomics is actively involved in addressing complex scientific challenges, making significant contributions to areas like cancer research, agricultural sustainability, and evolutionary biology.


6. Mission Bio

  • Website: missionbio.com
  • Ownership type: Venture Capital
  • Headquarters: South San Francisco, California, United States (USA)
  • Employee distribution: United States (USA) 95%, United Kingdom (UK) 2%, Netherlands 2%
  • Latest funding: Other (Debt), $40.0M, January 2022
  • Founded year: 2014
  • Headcount: 51-200
  • LinkedIn: mission-bio

Mission Bio, founded in 2014 and based in South San Francisco, California, is a biotechnology firm that focuses on single-cell technology and genomic analysis. The company provides innovative tools and services tailored for biopharmaceutical companies and research institutions, with a strong emphasis on oncology research, precision medicine, and genome editing. Their flagship product, the Tapestri Platform, is designed to facilitate multi-omics analysis, allowing researchers to simultaneously measure genetic variations and protein data from individual cells. This capability is crucial for understanding the complexities of cancer and supporting drug development efforts. Mission Bio has received significant funding, with a reported amount of $40 million in 2022, indicating strong investor confidence in their technology and market potential. The company continues to play a vital role in the bioinformatics industry by offering solutions that enhance the understanding of cancer biology and improve therapeutic strategies.


7. SeqMatic

  • Website: seqmatic.com
  • Ownership type: Private
  • Headquarters: Fremont, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2012
  • Headcount: 11-50
  • LinkedIn: seqmatic

SeqMatic, founded in 2012 and based in Fremont, California, is a private company that provides specialized genomics services. With a team of 22 employees, SeqMatic focuses on next-generation sequencing and omics research solutions. They cater primarily to businesses and research institutions in the biotechnology and pharmaceutical sectors. Their offerings include a wide range of services such as DNA and RNA sequencing, bioinformatics, and histopathology. SeqMatic operates from a state-of-the-art laboratory, ensuring high-quality and timely service. They are recognized as a certified service provider by Illumina and 10x Genomics, which underscores their credibility in the industry. Their commitment to customer satisfaction is evident in their tailored services and rapid turnaround times, making them a valuable partner for scientific discovery.


8. Edico Genome

  • Website: edicogenome.com
  • Ownership type: Corporate
  • Headquarters: San Diego, California, United States (USA)
  • Latest funding: $100.0M, May 2018
  • Founded year: 2013
  • Headcount: 51-200
  • LinkedIn: edico-genome

Edico Genome is a biotechnology company based in San Diego, California, founded in 2013. The company specializes in bioinformatics, particularly focusing on genomic data analysis. Edico Genome is recognized for its DRAGEN (Dynamic Read Analysis for GENomics) platform, which provides rapid and accurate secondary analysis of next-generation sequencing data. This platform is designed to streamline the workflow for researchers and clinical laboratories, enabling them to derive insights from genomic data more efficiently. The company has received substantial funding, amounting to $100 million, which underscores its potential and commitment to advancing genomic research and applications in healthcare. Edico Genome's innovative solutions are pivotal in enhancing the capabilities of genomic analysis, making it a significant player in the bioinformatics industry.


9. Spatial Genomics, Inc.

  • Website: spatialgenomics.com
  • Ownership type: Corporate
  • Headquarters: Pasadena, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series A, $56.0M, February 2022
  • Founded year: 2016
  • Headcount: 11-50
  • LinkedIn: spatialgenomics

Spatial Genomics, Inc., founded in 2016 and based in Pasadena, California, is a biotechnology company focused on spatial genomics and biomolecular analysis. The firm offers cutting-edge tools, including the GenePS device and seqFISH technology, which empower researchers in both academia and industry to conduct high-resolution studies of gene expression and cellular interactions. Their innovative approach allows for the examination of single-cell gene expression, protein expression, and genomic states within intact cells and tissues. This capability is essential for understanding complex biological systems and advancing precision medicine. In February 2022, Spatial Genomics secured $56 million in Series A funding, underscoring its potential for growth and innovation in the bioinformatics sector. The company aims to make spatial analysis a standard tool in laboratories worldwide, contributing to advancements in drug development and diagnostics.


10. Jumpcode Genomics

  • Website: jumpcodegenomics.com
  • Ownership type: Venture Capital
  • Headquarters: San Diego, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series B, $21.0M, January 2021
  • Founded year: 2016
  • Headcount: 11-50
  • LinkedIn: jumpcodegenomics

Jumpcode Genomics, founded in 2016 and based in San Diego, California, is a biotechnology firm that specializes in genomic analysis and RNA sequencing technologies. The company aims to enhance the sensitivity and specificity of genomic data, catering to researchers and biopharma companies. Their product offerings include innovative kits like DepleteX and CRISPRclean, which are designed to remove unwanted sequences from next-generation sequencing (NGS) libraries. This technology is particularly useful in applications such as single-cell sequencing, infectious disease surveillance, and microbiome studies. Jumpcode Genomics has received significant venture capital funding, with their last funding round raising $21 million in January 2021. This financial backing supports their ongoing development and expansion in the bioinformatics field, making them a relevant player in the industry.


11. Cellecta, Inc.

  • Website: cellecta.com
  • Ownership type: Private
  • Headquarters: Mountain View, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2006
  • Headcount: 11-50
  • LinkedIn: cellecta-inc-

Cellecta, Inc., founded in 2006 and based in Mountain View, California, is a private biotechnology company that specializes in genetic research and analysis. With a team of approximately 28 employees, Cellecta focuses on providing a range of services and products that cater to the needs of researchers and organizations in the biotech and pharmaceutical sectors. Their offerings include CRISPR and RNAi screening, immune receptor profiling, and custom libraries. These services are designed to enhance research capabilities, particularly in drug target and biomarker discovery. Cellecta's innovative solutions are integral to advancing genetic research, making them a notable player in the bioinformatics industry.


12. BioDiscovery

  • Website: biodiscovery.com
  • Ownership type: Corporate
  • Headquarters: El Segundo, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: $100.0M, October 2021
  • Founded year: 1997
  • Headcount: 201-500
  • LinkedIn: biodiscovery

BioDiscovery, operating under the name Bionano Genomics, Inc., is a biotechnology firm based in El Segundo, California. Founded in 1997, the company focuses on optical genome mapping and genetic analysis, providing advanced systems and software solutions to researchers and laboratories. Their flagship products include the Stratys™ and Saphyr™ systems, which enable the accurate detection of structural variants in genomic data. These tools are particularly valuable in the fields of oncology and genetic diseases, where understanding genetic variations is crucial for research and treatment. BioDiscovery also offers a range of software solutions, including VIA™ Software and Nexus Copy Number, which facilitate data analysis and interpretation. The company has secured substantial funding, with a reported amount of $100 million in October 2021, underscoring its active role in the biotechnology sector and its commitment to advancing genomic research.


13. Elucidata

  • Website: elucidata.io
  • Ownership type: Venture Capital
  • Headquarters: San Francisco, California, United States (USA)
  • Employee distribution: India 91%, United States (USA) 9%
  • Latest funding: Series A, $16.0M, September 2022
  • Founded year: 2015
  • Headcount: 51-200
  • LinkedIn: elucidata-corporation

Elucidata, founded in 2015 and based in San Francisco, California, is a biotechnology company that specializes in bioinformatics solutions. The company offers the Polly platform, a cloud-based service that facilitates the harmonization and analysis of biomedical data. This platform is particularly beneficial for biopharma companies and research institutions, as it enables them to leverage multi-omics data effectively, thereby accelerating the drug discovery process. Elucidata's services include data curation, visualization, and the development of custom bioinformatics pipelines. With a workforce of approximately 158 employees, predominantly located in India, the company has demonstrated significant growth and innovation in the bioinformatics field. Their recent Series A funding of $16 million in September 2022 further underscores their potential and relevance in the industry.


14. Genoox

  • Website: genoox.com
  • Ownership type: Venture Capital
  • Headquarters: Palo Alto, California, United States (USA)
  • Employee distribution: Israel 90%, Spain 5%, Germany 5%
  • Latest funding: Series B, $8.0M, February 2021
  • Founded year: 2014
  • Headcount: 11-50
  • LinkedIn: genoox

Genoox, founded in 2014 and based in Palo Alto, California, is a healthcare technology company focused on genomic data analysis and solutions. The company offers a platform that provides actionable insights for clinical genetics, biopharma, and healthcare systems. Their mission is to optimize patient care and accelerate drug development by leveraging genomic data. Genoox operates globally, serving healthcare providers and research institutions, and emphasizes a community-driven approach to enhance genomic insights. The company has been deployed in 44 countries and collaborates with over 1,700 organizations. In February 2021, Genoox raised $8 million in a Series B funding round, which underscores its growth and commitment to advancing genomic data accessibility and utility in clinical settings.


15. SciGenom Labs

  • Website: scigenom.com
  • Ownership type: Private
  • Headquarters: San Francisco, California, United States (USA)
  • Employee distribution: India 100%
  • Founded year: 2010
  • Headcount: 11-50
  • LinkedIn: scigenomlabs

SciGenom Labs, founded in 2010 and based in San Francisco, California, operates primarily out of Kochi, India. This private company serves as a biotechnology incubator, focusing on Next Generation Sequencing (NGS) technologies to create and support startups in genomics, diagnostics, and agricultural sectors. They provide essential services such as DNA sequencing and bioinformatics analysis, addressing significant challenges in healthcare and agriculture. SciGenom Labs has successfully incubated several companies, including MedGenome, which specializes in genetic diagnostics, and AgriGenome, which focuses on agricultural genomics. The company has established a recognized lab in Kochi, contributing to the scientific community through research and education initiatives. Their commitment to fostering innovation in biotechnology makes them a notable entity in the bioinformatics industry.


16. Cantata Bio

  • Website: cantatabio.com
  • Ownership type: Private
  • Headquarters: Scotts Valley, California, United States (USA)
  • Employee distribution: United States (USA) 86%, Spain 14%
  • Founded year: 2022
  • Headcount: 51-200
  • LinkedIn: cantata-bio

Cantata Bio, founded in 2022 and based in Scotts Valley, California, is a biotechnology firm that specializes in genomic, epigenomic, and metagenomic solutions. The company aims to empower researchers and clinicians by providing advanced tools and services that address complex scientific challenges across various fields, including human health and agriculture. Through its subsidiaries, Dovetail Genomics and Arc Bio, Cantata Bio offers innovative multi-omic products that unlock access to genomic information at unprecedented levels. Their key competencies include integrated metagenomics workflows and long-range sequencing assays, which are essential for applications in epigenetics, cancer research, and microbial profiling. Cantata Bio's commitment to enhancing research capabilities positions it as a significant player in the bioinformatics industry.


17. Probius

  • Website: probius.bio
  • Ownership type: Venture Capital
  • Headquarters: Fremont, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Seed, December 2023
  • Founded year: 2016
  • Headcount: 11-50
  • LinkedIn: probius

Probius, founded in 2016 and based in Fremont, California, is a biotechnology company that specializes in bioanalytical solutions that leverage artificial intelligence for biological data analysis. The company has developed a unique technology known as Quantum Electrochemical Spectroscopy (QES), which allows researchers and organizations in the biotechnology and healthcare sectors to detect and quantify proteins, metabolites, and cells with minimal sample volume and no need for reagents or extensive sample preparation. This capability accelerates the pace of research in biosciences, enabling faster disease discovery and drug development. Probius actively seeks collaboration through its QESLab program, which funds projects utilizing the QES platform, thereby fostering innovation in bioanalysis. The company operates entirely within the United States and has a small team of around 15 employees, reflecting its focused approach to advancing bioanalytical technologies.


18. Protein Lounge

  • Website: proteinlounge.com
  • Ownership type: Venture Capital
  • Headquarters: San Diego, California, United States (USA)
  • Employee distribution: India 73%, United States (USA) 27%
  • Latest funding: Seed, $1,000, June 2011
  • Founded year: 2003
  • Headcount: 11-50
  • LinkedIn: proteinlounge

Protein Lounge, founded in 2003 and based in San Diego, California, is a bioinformatics company dedicated to providing essential biological databases and tools for life scientists. The company specializes in systems biology, focusing on the intricate networks of cellular interactions and protein functions. Their offerings include comprehensive databases for proteins, kinases, transcription factors, and various biochemical compounds. Additionally, Protein Lounge has developed interactive tools such as the Pathway Builder and Protein Hydroplotter, which assist researchers in visualizing and analyzing complex biological data. The company serves a wide clientele, including academic researchers and pharmaceutical firms, helping them streamline their research and development processes. Despite not having received funding since 2011, Protein Lounge continues to be a relevant player in the bioinformatics sector, offering valuable resources to the scientific community.


19. Benchling

  • Website: benchling.com
  • Ownership type: Venture Capital
  • Headquarters: San Francisco, California, United States (USA)
  • Employee distribution: United States (USA) 86%, Switzerland 6%, United Kingdom (UK) 5%, Other 3%
  • Latest funding: Series E-K, $100.0M, November 2021
  • Founded year: 2012
  • Headcount: 501-1000
  • LinkedIn: benchling

Benchling is a biotechnology software company based in San Francisco, California, founded in 2012. The company specializes in providing a unified platform for research and development in life sciences, catering to scientists across various sectors, including pharmaceuticals and academia. Benchling's solutions are designed to streamline workflows, enhance collaboration, and improve data management in R&D processes. They support a wide range of applications, from antibody and protein development to gene and cell therapy, as well as microbial strain research. With a workforce of approximately 782 employees and significant funding of $100 million in November 2021, Benchling has established itself as a key player in the biotechnology software space, trusted by over 200,000 scientists from Fortune 500 companies, startups, and renowned academic institutions.


20. Ultima Genomics

  • Website: ultimagenomics.com
  • Ownership type: Private Equity
  • Headquarters: Fremont, California, United States (USA)
  • Employee distribution: United States (USA) 80%, Israel 18%, Other 2%
  • Latest funding: $600.0M, May 2022
  • Founded year: 2016
  • Headcount: 201-500
  • LinkedIn: ultimagenomics

Ultima Genomics, Inc. is a biotechnology company based in Fremont, California, founded in 2016. The company specializes in high-throughput genomic sequencing technologies, offering products like the UG 100™ Sequencer and ppmSeq for rare event detection. Ultima Genomics aims to make genomic information more affordable and accessible, which is crucial for both scientific research and medical applications. Their technology is designed to overcome the limitations of traditional sequencing methods, allowing for broader, deeper, and more frequent genomic analysis. With a workforce of around 309 employees, the company has attracted significant investment, raising approximately $600 million from various investors. This funding supports their mission to drive advancements in human health through innovative genomic solutions. Ultima Genomics collaborates with leading scientists and research institutions to push the boundaries of genomic research, demonstrating their commitment to enhancing the understanding of complex biological systems.


21. Alamar Biosciences, Inc.

  • Website: alamarbio.com
  • Ownership type: Venture Capital
  • Headquarters: Fremont, California, United States (USA)
  • Employee distribution: United States (USA) 94%, United Kingdom (UK) 3%, Other 3%
  • Latest funding: Other (Grant), $10.0M, January 2025
  • Founded year: 2018
  • Headcount: 51-200
  • LinkedIn: alamar-biosciences-inc

Alamar Biosciences, Inc., founded in 2018 and based in Fremont, California, is a biotechnology company that focuses on proteomics and biomarker analysis. The company offers innovative solutions such as the NULISA technology and the ARGO HT System, which enable researchers to detect protein biomarkers with high precision. Their products are designed for use in academic and biopharmaceutical research, supporting efforts in early disease diagnosis and personalized medicine. Alamar has received significant funding, including a recent grant of $10 million in January 2025, which underscores their commitment to advancing biomarker research. The company is actively involved in the scientific community, hosting events and publishing research that highlights their contributions to the field.


22. Unchained Labs

  • Website: unchainedlabs.com
  • Ownership type: Private Equity
  • Headquarters: Pleasanton, California, United States (USA)
  • Employee distribution: United States (USA) 60%, United Kingdom (UK) 14%, China 7%, Other 18%
  • Latest funding: Other (Debt), $155.0M, August 2021
  • Founded year: 2015
  • Headcount: 201-500
  • LinkedIn: unchained-labs

Unchained Labs, founded in 2015 and based in Pleasanton, California, is a private equity-backed company specializing in life sciences tools. The firm focuses on providing innovative solutions tailored for biologics and gene therapy research. Their product lineup includes advanced platforms for stability screening, quantification, and characterization of various biological samples. Unchained Labs aims to address significant scientific challenges faced by researchers in the biotechnology and pharmaceutical sectors. With a workforce of approximately 244 employees, the company has established a global presence, with a notable distribution of employees across the United States, the United Kingdom, and other countries. In August 2021, Unchained Labs secured $155 million in funding, which underscores investor confidence in their growth potential and market relevance. Their commitment to enhancing research efficiency positions them as a key player in the life sciences industry, particularly in the context of biologics and gene therapy.


23. Advanced Cell Diagnostics (ACD)

  • Website: acdbio.com
  • Ownership type: Corporate
  • Headquarters: Newark, California, United States (USA)
  • Employee distribution: United States (USA) 99%, Other 1%
  • Latest funding: $250.0M, July 2016
  • Founded year: 2006
  • Headcount: 51-200
  • LinkedIn: advanced-cell-diagnostics

Advanced Cell Diagnostics, Inc. is a biotechnology firm based in Newark, California, founded in 2006. The company specializes in RNA detection technologies, offering a range of assays and professional services tailored for researchers and biopharmaceutical companies. Their flagship products, such as RNAscope™ and BaseScope™, enable precise analysis of gene expression within tissue samples, facilitating advancements in therapeutic development. ACD's services extend to multiomic profiling, biomarker assay development, and clinical assay development, which are essential for modern research. The company has received significant funding, amounting to $250 million, which underscores its potential and relevance in the biotechnology sector. ACD operates primarily in the life sciences sector, focusing on applications in cancer research, neuroscience, and infectious diseases, among others.


24. Quantapore Inc.

  • Website: quantapore.com
  • Ownership type: Venture Capital
  • Headquarters: Menlo Park, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series C, $17.0M, July 2018
  • Founded year: 2009
  • Headcount: 11-50
  • LinkedIn: quantapore-inc.

Quantapore Inc., founded in 2009 and based in Menlo Park, California, is a biotechnology firm dedicated to advancing analytical platforms for genomics and proteomics. The company specializes in the design of single-molecule, solid-state nanopore-based analytical tools. These tools are intended to address significant challenges faced by researchers in the life sciences, particularly in the areas of protein analysis and genomic sequencing. Quantapore's innovative approach aims to improve human health by enhancing the capabilities of researchers and scientists. The company has attracted substantial venture capital, securing $17 million in its Series C funding round in July 2018, which underscores its potential and relevance in the biotechnology and bioinformatics sectors.



Bioinformatics Insights: Key Companies in California


CompanyHeadquarterSizeFoundedOwnership
DNAnexusMountain View, California, United States (USA)201-5002009Private Equity
Partek, an Illumina companySan Diego, California, United States (USA)11-501993Private
Ingenuity Web AppsRedwood City, California, United States (USA)51-2001998Corporate
Arima GenomicsCarlsbad, California, United States (USA)11-502015Venture Capital
Dovetail GenomicsScotts Valley, California, United States (USA)11-502013Private
Mission BioSouth San Francisco, California, United States (USA)51-2002014Venture Capital
SeqMaticFremont, California, United States (USA)11-502012Private
Edico GenomeSan Diego, California, United States (USA)51-2002013Corporate
Spatial Genomics, Inc.Pasadena, California, United States (USA)11-502016Corporate
Jumpcode GenomicsSan Diego, California, United States (USA)11-502016Venture Capital
Cellecta, Inc.Mountain View, California, United States (USA)11-502006Private
BioDiscoveryEl Segundo, California, United States (USA)201-5001997Corporate
ElucidataSan Francisco, California, United States (USA)51-2002015Venture Capital
GenooxPalo Alto, California, United States (USA)11-502014Venture Capital
SciGenom LabsSan Francisco, California, United States (USA)11-502010Private
Cantata BioScotts Valley, California, United States (USA)51-2002022Private
ProbiusFremont, California, United States (USA)11-502016Venture Capital
Protein LoungeSan Diego, California, United States (USA)11-502003Venture Capital
BenchlingSan Francisco, California, United States (USA)501-10002012Venture Capital
Ultima GenomicsFremont, California, United States (USA)201-5002016Private Equity
Alamar Biosciences, Inc.Fremont, California, United States (USA)51-2002018Venture Capital
Unchained LabsPleasanton, California, United States (USA)201-5002015Private Equity
Advanced Cell Diagnostics (ACD)Newark, California, United States (USA)51-2002006Corporate
Quantapore Inc.Menlo Park, California, United States (USA)11-502009Venture Capital


Want to Find More Bioinformatics Companies?

If you want to find more companies that offer innovative solutions for genomic data analysis and research you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!